Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Hexyon versus Infanrix hexa in infants, with concomitant Prevenar 13
2012-001055-39Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Hexyon in diphtheria, Tetanus, pertussis and 5 more (3 arms), sponsored by Sanofi. Primary endpoint: Immunogenicity in Groups 1 and 2. Started Oct 2013; status: completed.
02
Drugs
Hexyon
03
Conditions
diphtheriaTetanuspertussispoliomyelitishepatitis B (HBV)
Beyond the preview
Go deeper on 2012-001055-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001055-39.